| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.6 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.7 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.7 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.023 | 0.7 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |